University of Washington School of Medicine, Department of Psychiatry & Behavioral Sciences, United States of America.
University of Washington School of Medicine, Department of Psychiatry & Behavioral Sciences, United States of America.
Gen Hosp Psychiatry. 2022 Sep-Oct;78:108-110. doi: 10.1016/j.genhosppsych.2022.08.001. Epub 2022 Aug 4.
To compare medication treatment of individuals with bipolar disorder in two primary care-based integrated care models.
Participants were randomized to 12-months of treatment with direct care by co-located psychiatrists in primary care, or collaborative care (primary care clinicians supported by psychiatrists). Medication data at initial and last treatment visits were extracted from the clinical registry for 191 patients diagnosed with bipolar disorder.
Participants receiving no medication treatment decreased from 28% to 11% (direct co-located) (χ = 10.9, p < .001) and 39% to 17% (collaborative care; χ = 16.9, p < .001). Last visit medication prescriptions for antipsychotic medication (approximately one-half of participants) increased significantly compared to initial visit and did not differ between arms. Anticonvulsant mood-stabilizing medication (approximately one-third of participants in both arms) was higher than lithium prescription (approximately 6% of participants) at last visit.
Similar patterns of medication treatment were observed in participants with bipolar disorder receiving either direct care from psychiatrists, or medication treatment by primary care clinicians supported by psychiatrists.
比较两种基于初级保健的综合护理模式中双相情感障碍患者的药物治疗情况。
参与者被随机分配到 12 个月的治疗中,分别由初级保健中的联合精神病医生直接护理,或协作护理(由精神病医生支持的初级保健临床医生)。从临床登记处提取了 191 名被诊断为双相情感障碍的患者在初始和最后治疗就诊时的药物数据。
未接受药物治疗的参与者从 28%降至 11%(直接联合护理;χ²=10.9,p<.001)和 39%降至 17%(协作护理;χ²=16.9,p<.001)。与初始就诊相比,最后就诊时抗精神病药物(约一半参与者)的处方显著增加,且两组之间无差异。抗惊厥情绪稳定剂药物(约三分之一的参与者)高于锂盐处方(约 6%的参与者)。
在接受直接由精神病医生提供的护理或由精神病医生支持的初级保健临床医生提供药物治疗的双相情感障碍患者中,观察到相似的药物治疗模式。